Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 06:06 am Unchanged |
2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Rubric Capital Management LP | 5,684,420 8.900% |
0 (Unchanged) |
Filing History |
| 2024-02-12 06:06 am Sale |
2023-12-31 | 13G | Telesat Corporation TSAT |
Rubric Capital Management LP | 959,764 7.120% |
-450,236 (-31.93%) |
Filing History |
| 2024-01-23 4:00 pm Sale |
2024-01-19 | 13D | Xperi Holding Corporation XPER |
Rubric Capital Management LP | 3,301,219 7.600% |
-542,525 (-14.11%) |
Filing History |
| 2023-11-20 08:45 am Purchase |
2023-11-16 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 99,704,885 14.220% |
2,378,330 (+2.44%) |
Filing History |
| 2023-11-17 09:28 am Purchase |
2023-11-15 | 13D | TherapeuticsMD, Inc. TXMD |
Rubric Capital Management LP | 2,946,908 25.730% |
877,192 (+42.38%) |
Filing History |
| 2023-11-15 07:56 am Purchase |
2023-11-13 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 97,326,555 13.880% |
7,200 (+0.01%) |
Filing History |
| 2023-11-13 07:31 am Purchase |
2023-11-09 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 97,319,355 13.880% |
1,758,195 (+1.84%) |
Filing History |
| 2023-11-08 07:06 am Purchase |
2023-11-06 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 95,561,160 13.630% |
2,188,575 (+2.34%) |
Filing History |
| 2023-11-06 07:30 am Purchase |
2023-11-03 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 93,372,585 13.320% |
1,081,380 (+1.17%) |
Filing History |
| 2023-11-02 07:30 am Purchase |
2023-10-31 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 92,291,205 13.250% |
92,130 (+0.10%) |
Filing History |
| 2023-10-30 6:02 pm Purchase |
2023-10-27 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 92,199,075 13.150% |
2,168,475 (+2.41%) |
Filing History |
| 2023-07-25 4:13 pm Purchase |
2023-07-21 | 13D | Heron Therapeutics, Inc. HRTX |
Rubric Capital Management LP | 26,713,503 19.000% |
14,963,503 (+127.35%) |
Filing History |
| 2023-06-30 08:29 am Purchase |
2023-06-28 | 13D | TherapeuticsMD, Inc. TXMD |
Rubric Capital Management LP | 2,069,716 19.570% |
347,763 (+20.20%) |
Filing History |
| 2023-06-16 08:00 am Purchase |
2023-06-14 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 90,030,600 14.410% |
6,250,000 (+7.46%) |
Filing History |
| 2023-05-02 5:07 pm Sale |
2023-04-30 | 13G | Chimerix, Inc. CMRX |
Rubric Capital Management LP | 4,779,020 5.390% |
-2,720,980 (-36.28%) |
Filing History |
| 2023-02-22 4:24 pm Unchanged |
2023-02-21 | 13D | Heron Therapeutics, Inc. HRTX |
Rubric Capital Management LP | 11,750,000 9.900% |
0 (Unchanged) |
Filing History |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Digimarc Corporation DMRC |
Rubric Capital Management LP | 1,214,593 6.060% |
1,214,593 (New Position) |
Filing History |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | BGC Partners, Inc. BGCP |
Rubric Capital Management LP | 18,250,000 5.640% |
18,250,000 (New Position) |
Filing History |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Amryt Pharma plc AMYT |
Rubric Capital Management LP | 18,000,000 5.610% |
277,660 (+1.57%) |
Filing History |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Rubric Capital Management LP | 3,333,628 9.930% |
727,128 (+27.90%) |
Filing History |